Sullivan Timothy Eugene 4
4 · Apellis Pharmaceuticals, Inc. · Filed Jan 30, 2026
Research Summary
AI-generated summary of this filing
Apellis (APLS) CFO Timothy Sullivan Receives 58,140 RSUs
What Happened
Timothy E. Sullivan, Chief Financial Officer of Apellis Pharmaceuticals (APLS), received a grant of 58,140 restricted stock units (RSUs) on January 28, 2026. The filing reports an acquisition at $0.00 per share (typical for RSU awards); no cash was paid. The Form 4 lists the transaction as an award/grant (code A).
Key Details
- Transaction date: 2026-01-28; Form 4 filed 2026-01-30 (timely filing).
- Security: 58,140 RSUs reported at $0.00 per share.
- Shares owned after transaction: Not specified in the provided filing details.
- Footnote highlights:
- F1: RSUs vest 25% annually over four years from the grant date, subject to continued service.
- F2: The securities are held by The Timothy E Sullivan Irrevocable Trust of 2023; Patrick O. Collins is trustee. Sullivan disclaims beneficial ownership except to the extent of his pecuniary interest.
Context
RSU grants are a common form of executive compensation and vest over time; they are not an open-market purchase or sale and therefore are a limited signal of immediate insider sentiment. As the RSUs vest (25% per year), the underlying shares may become reportable insider holdings and could be sold or retained in the future per company and SEC rules.
Insider Transaction Report
- Award
Common Stock
[F1]2026-01-28+58,140→ 152,041 total
- 60,396(indirect: By Trust)
Common Stock
[F2]
Footnotes (2)
- [F1]This represents a Restricted Stock Unit award granted on January 28, 2026 that vest 25% annually over four years from grant date subject to continued service.
- [F2]The securities are held by The Timothy E Sullivan Irrevocable Trust of 2023. Patrick O. Collins is the trustee of The Timothy E Sullivan Irrevocable Trust of 2023. The reporting person disclaims beneficial ownership over the shares held by The Timothy E Sullivan Irrevocable Trust of 2023 except to the extent of his pecuniary interest therein.